Tevogen Bio Holdings Inc. (NASDAQ: TVGN ), currently valued at $229 million, reported Thursday that its Board of Directors approved restricted stock award grants on June 27, including 8,000,000 restricted shares to Chief Executive Officer and Chairperson Dr. Ryan Saadi. According to InvestingPro data, the company's stock has delivered an impressive 80% return over the past year. As a result of these grants, the company stated that the total number of outstanding shares of common stock as of Thursday is 193,693,433. According to the company's press release statement, the restricted shares granted to Dr. Saadi will vest in four equal annual installments beginning on the seventh anniversary of the grant date. Restricted shares granted to other recipients will vest in three equal annual installments beginning on the fifth anniversary of the grant date.